+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oxazolidinones"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
DNA topoisomerase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

DNA topoisomerase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Oxazolidinones are a class of antibiotics used to treat a variety of bacterial infections. They are bacteriostatic, meaning they inhibit the growth of bacteria, rather than killing them. Oxazolidinones are generally used to treat infections caused by Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae. They are also used to treat infections caused by some Gram-negative bacteria, such as Pseudomonas aeruginosa. Oxazolidinones are generally well-tolerated and have few side effects. Oxazolidinones are an important part of the antibiotics market, as they are effective against a wide range of bacterial infections. They are often used as a first-line treatment for infections caused by Gram-positive bacteria, and are increasingly being used to treat infections caused by Gram-negative bacteria. Some companies in the Oxazolidinones market include Merck & Co., Inc., Pfizer, Inc., and Allergan plc. Show Less Read more